Join us in Las Vegas for this

Midday Symposium Conducted at the 2022 ASHP Midyear Clinical Meeting & Exhibition!

JAK Inhibitors and the Changing Landscape of Atopic Dermatitis and Alopecia Areata Management

This case-based educational activity will include an overview of atopic dermatitis (AD) and alopecia areata (AA), the pathophysiology, and the impact of each disease on patient quality of life, including comorbidities and associated health costs. New and emerging therapies will be discussed, including Janus kinase (JAK) inhibitors, to help pharmacists identify appropriate patient selection for these agents. Faculty will provide pearls to assist pharmacists caring for patients with AD and AA.

Tuesday, Dec. 6

11:30 a.m. - 1 p.m. PT

Come early! Seating is limited and provided on a first-come, first-served basis.

Symposium Location: Islander Ballroom I, Lower Level, Mandalay Bay North Convention Center

Can't Make it to Vegas? Tune into the Live Webinar Broadcast: 

Tuesday, Dec. 6

11:30 a.m. - 1 p.m. PT (2:30 - 4 p.m. ET)

Registration is required for the webinar.  

Featuring...

Jamie L. McConaha

PharmD, NCTTP, BCACP, CDCES
Activity Chair

Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy
Pittsburgh, Pennsylvania

Monica Dougherty

PharmD, BCACP

Clinical Pharmacy Specialist
University of Rochester Medical Center
Rochester, New York

Target Audience

This activity was planned to meet the educational needs of pharmacists involved in the care of patients with atopic dermatitis and alopecia areata.

Learning Objectives

• Discuss the impact of atopic dermatitis (AD) and alopecia areata (AA) on quality of life, comorbidities, and associated health costs.
• Analyze safety and efficacy data, novel mechanisms of action, and routes of administration of current and emerging treatments for AD and AA.
• Design a treatment plan for a variety of atopic dermatitis and alopecia patient cases, incorporating newer evidence-based therapies.
• Identify the role of the pharmacist in caring for patients with AD and AA.

Agenda

11:30 a.m. - Welcome and Introductions
Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES

11:35 a.m. - Burden of Atopic Dermatitis (AD) and Alopecia Areata (AA)
Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES

11:50 a.m. - Treatment Landscape

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES and Monica Dougherty, PharmD, BCACP

12:30 p.m. - Role of the Pharmacist

Monica Dougherty, PharmD, BCACP

12:50 p.m. - Faculty Discussion and Questions & Answers
Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES and Monica Dougherty, PharmD, BCACP

Accredited for CPE

ACPE #: 0204-0000-22-419-L01-P

CE Credit: 1.5 contact hours (0.15 CEUs)

Activity Type: Application-based

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Provided by ASHP.
Supported by an educational grant from Pfizer Inc.
For questions and assistance to participate, contact us.